EFFICACY AND SAFETY OF THE USE OF CETUXIMAB IN PATIENTS WITH METASTATIC COLORECTAL CANCER

被引：0
|
作者：
Croci, A. [1 ]
Aleman, A. [1 ]
Perez Galan, A. [1 ]
机构：
[1] Minist Publ Hlth, Montevideo, Uruguay
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.230
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN2
引用
收藏
页码：A815 / A815
页数：1
相关论文
共 50 条
  • [31] EFFICACY OF CETUXIMAB/PANITUMUMAB AFTER PREVIOUS BEVACIZUMAB IN METASTATIC COLORECTAL CANCER
    Gherman, Alexandra
    Cainap, Calin
    Vesa, Stefan-Cristian
    Havasi, Andrei Dan
    Trifon, Alexandra
    Cainap, Simona Sorana
    Crisan, Ovidiu
    Irimie, Alexandru
    FARMACIA, 2020, 68 (04) : 656 - 664
  • [32] Genetic and immune factors underlying the efficacy of cetuximab and panitumumab in the treatment of patients with metastatic colorectal cancer
    Krawczyk, Pawel Adam
    Kowalski, Dariusz M.
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2014, 18 (01): : 7 - 16
  • [33] Efficacy and safety of XELIRI plus cetuximab versus XELOX plus cetuximab in first-line treatment of metastatic colorectal cancer (mCRC)
    Ocvirk, J.
    Boc, M.
    Rebersek, M.
    Mesti, T.
    Ebert, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [34] Cetuximab - In the treatment of metastatic colorectal cancer
    Reynolds, NA
    Wagstaff, AJ
    DRUGS, 2004, 64 (01) : 109 - 118
  • [35] Cetuximab for treatment of metastatic colorectal cancer
    Cerea, G.
    Ricotta, R.
    Schiavetto, I.
    Maugeri, M. R.
    Sartore-Bianchi, A.
    Moroni, M.
    Artale, S.
    Siena, S.
    ANNALS OF ONCOLOGY, 2006, 17 : VII66 - VII67
  • [36] Cetuximab or bevacizumab in metastatic colorectal cancer?
    Sclafani, Francesco
    Cunningham, David
    LANCET ONCOLOGY, 2014, 15 (10): : 1040 - 1041
  • [37] Cetuximab in the treatment of metastatic colorectal cancer
    Moosmann, Nicolas
    Heinemann, Volker
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (02) : 243 - 256
  • [38] Cetuximab in metastatic colorectal cancer Reply
    Folprecht, Gunnar
    Koehne, Claus-Henning
    LANCET ONCOLOGY, 2010, 11 (04): : 314 - 314
  • [39] Safety and efficacy of panitumumab therapy after metastatic colorectal cancer progression with cetuximab: Experience at a single Japanese institution
    Sonoda, Hiromichi
    Mekata, Eiji
    Shimizu, Tomoharu
    Endo, Yoshihiro
    Tani, Tohru
    ONCOLOGY LETTERS, 2013, 5 (04) : 1331 - 1334
  • [40] Retrospective cohort study on the safety and efficacy of cetuximab for metastatic colorectal cancer patients: HGCSG0901-Analysis of predictive markers.
    Hatanaka, Kazuteru
    Yuki, Satoshi
    Nakatsumi, Hiroshi
    Kogawa, Takahiro
    Fukushima, Hiraku
    Fujikawa, Koshi
    Sato, Yasushi
    Saito, Mayuko
    Munakata, Masaki
    Komatsu, Yoshito
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
12345